title: Breakthrough Fusarium solani infection in a patient with acute myeloid leukemia receiving posaconazole prophylaxis.
authors.affiliation: Division of Hematology-Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, 100 Tzyou 1st Road, 807, Kaohsiung, Taiwan.
authors.forename: Cheng-Han
authors.initials: CH
authors.lastname: Wu
authors.forename: Po-Liang
authors.initials: PL
authors.lastname: Lu
authors.forename: Hui-Hua
authors.initials: HH
authors.lastname: Hsiao
authors.forename: Ta-Chih
authors.initials: TC
authors.lastname: Liu
authors.forename: Sheng-Fung
authors.initials: SF
authors.lastname: Lin
authors.forename: Chao-Sung
authors.initials: CS
authors.lastname: Chang
authors.forename: Jui-Feng
authors.initials: JF
authors.lastname: Hsu
authors.forename: Yi-Chang
authors.initials: YC
authors.lastname: Liu
mesh_terms: D000666:Amphotericin B / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000935:Antifungal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D003561:Cytarabine / Q000008:administration & dosage; D025141:Drug Resistance, Fungal; D017809:Fatal Outcome; D005260:Female; D005334:Fever / Q000209:etiology; D060585:Fusariosis / Q000209:etiology* / Q000517:prevention & control; D005670:Fusarium / Q000187:drug effects / Q000302:isolation & purification*; D006801:Humans; D015255:Idarubicin / Q000008:administration & dosage; D015470:Leukemia, Myeloid, Acute / Q000150:complications* / Q000188:drug therapy; D014230:Triazoles / Q000008:administration & dosage / Q000627:therapeutic use*; D055815:Young Adult
chemical_list: D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D014230:Triazoles; D003561:Cytarabine; C101425:posaconazole; D000666:Amphotericin B; D015255:Idarubicin